Caroline Morse

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
There have been dramatic advancements in the treatment of chronic hepatitis C (HCV) infection. This is largely due to the approval of several direct-acting antiviral agents (DAAs) from a variety of medication classes with novel mechanisms of action. These therapies are a welcomed advancement given their improved efficacy and tolerability compared to(More)
  • 1